Actively Recruiting
The 3rd COPENHAGEN Puberty Study
Led by Rigshospitalet, Denmark · Updated on 2024-01-10
3000
Participants Needed
1
Research Sites
1774 weeks
Total Duration
On this page
Sponsors
R
Rigshospitalet, Denmark
Lead Sponsor
E
Environmental Protection Agency (EPA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The COPENHAGEN School Study is a combined cross-sectional and longitudinal study of healthy Danish school children. This study will by clinical examinations and withdrawal of blood samples investigate whether age of pubertal onset is continuing to decline in Denmark over the past 15 years. Furthermore, we will investigate the mechanism driving earlier onset of puberty and the long term health risks of extremely early puberty using Danish registry data
CONDITIONS
Official Title
The 3rd COPENHAGEN Puberty Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy children and adolescents
You will not qualify if you...
- Acute disease, cancer, cancer therapy, or chronic disease such as malignant disease, chemotherapy or radiation, cystic fibrosis, juvenile rheumatoid arthritis, systemic lupus erythematosus, sickle cell disease, thalassemia, chronic renal disease, or known numerical chromosome aberration
- Non-Caucasian
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet, Department of Growth and Reproduction
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
A
Anders Juul, PhD, DMSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here